Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · IEX Real-Time Price · USD
3.980
-0.010 (-0.25%)
At close: Apr 23, 2024, 4:00 PM
4.020
+0.040 (1.01%)
After-hours: Apr 23, 2024, 7:59 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $359.45 million as of April 23, 2024. Its market cap has increased by 28.01% in one year.
Market Cap
359.45M
Enterprise Value
57.73M
1-Year Change
28.01%
Ranking
Category
Stock Price
$3.98
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $359.45M, a decrease of -59.54%. That is a compound annual growth rate of -28.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2024 | 360.40M | 3.65% |
| Apr 19, 2024 | 347.70M | -1.53% |
| Apr 18, 2024 | 353.10M | - |
| Apr 17, 2024 | 353.10M | -2.51% |
| Apr 16, 2024 | 362.20M | -1.47% |
| Apr 15, 2024 | 367.60M | -3.08% |
| Apr 12, 2024 | 379.30M | -3.02% |
| Apr 11, 2024 | 391.10M | -0.46% |
| Apr 10, 2024 | 392.90M | -2.46% |
| Apr 9, 2024 | 402.80M | 2.29% |
| Apr 8, 2024 | 393.80M | -3.10% |
| Apr 5, 2024 | 406.40M | -0.88% |
| Apr 4, 2024 | 410.00M | -3.00% |
| Apr 3, 2024 | 422.70M | -2.08% |
| Apr 2, 2024 | 431.70M | -5.35% |
| Apr 1, 2024 | 456.10M | -1.74% |
| Mar 28, 2024 | 464.20M | 0.39% |
| Mar 27, 2024 | 462.40M | 1.18% |
| Mar 26, 2024 | 457.00M | -4.35% |
| Mar 25, 2024 | 477.80M | 1.16% |
| Mar 22, 2024 | 472.30M | -0.40% |
| Mar 21, 2024 | 474.20M | -4.18% |
| Mar 20, 2024 | 494.90M | 1.66% |
| Mar 19, 2024 | 486.80M | 3.16% |
| Mar 18, 2024 | 471.90M | -2.70% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 355.94M |
| Rani Therapeutics Holdings | 354.61M |
| Amarin Corporation | 351.30M |
| Alto Neuroscience | 348.42M |
| Adaptive Biotechnologies | 348.22M |
| Tactile Systems Technology | 342.14M |
| PepGen | 341.22M |
| Ocugen | 339.67M |